Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class

Treatment with a second JAKi is effective and safe in patients with UC already exposed to JAKi. Primary failure to a first JAKi and steroid use at initiation of the second JAKi might reduce the likelihood of success with the second JAKi.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-10-29
DOI
https://doi.org/10.1093/ecco-jcc/jjaf188
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class

Triana Lobatón, Mette Julsgaard, Alice De Bernardi, Martin Lukáš et al.
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
article

Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class

Triana Lobatón, Mette Julsgaard, Alice De Bernardi, Martin Lukáš, María José Casanova, Alessia Todeschini, Annalisa Aratari, Hannah Gordon, Gerassimos J. Mantzaris, Mathieu Uzzan, Lieven Pouillon, Anneline Cremer, Marie Truyens, Nurulamin M Noor, Andreas Blesl, Gisela Piñero, Franco Scaldaferri, Ana Gutiérrez, Ploutarchos Pastras, Giammarco Mocci, Alessandro Armuzzi, Gabriele Dragoni, Alessandro Quadarella, Charlotte Hedin, Tommaso Innocenti, Paola Balestrieri, Laura Ramos, Flavio Caprioli, Daniela Pugliese, Edoardo Vincenzo Savarino, Konstantinos Κarmiris, Concetta Ferracane, Sara Nikolić, Jurij Hanžel, Lorenzo Bertani, Carla Felice, Ioannis E. Κoutroubakis, Konstantinos Argyriou, Olga Maria Nardone, Tommaso Lorenzo Parigi, Sara Onali, Marko Brinar, Giorgos D. Michalopoulos, María José García, Milagros Vela González, Tamás Molnár
article en

Abstract

Treatment with a second JAKi is effective and safe in patients with UC already exposed to JAKi. Primary failure to a first JAKi and steroid use at initiation of the second JAKi might reduce the likelihood of success with the second JAKi.

Journal of Crohn s and ColitisVol. 20(2)
Università Cattolica del Sacro Cuore (IT), HOGENT University of Applied Sciences and Arts (BE), Karolinska University Hospital (SE), Humanitas University (IT), University of Padua (IT), University Hospital Centre Zagreb (HR), École nationale des ponts et chaussées (FR), University of Ljubljana (SI), Vita-Salute San Raffaele University (IT), University of Cagliari (IT), University of Milan (IT), University of Ioannina (GR), Medical University of Graz (AT), Aarhus University (DK), University of Szeged (HU), Hospital Universitario de Canarias (ES), Ghent University Hospital (BE), Ljubljana University Medical Centre (SI), General University Hospital of Patras (GR), Erasmus Hospital (BE), Aarhus University Hospital (DK), Cambridge University Hospitals NHS Foundation Trust (GB), Agostino Gemelli University Polyclinic (IT), John Radcliffe Hospital (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Karolinska Institutet (SE), Centre Hospitalier Universitaire Henri-Mondor (FR), Ghent University (BE), University of Maribor (SI), Hospital Universitario Nuestra Señora de Candelaria (ES), Ospedale San Filippo Neri (IT), Hellenic Red Cross (GR), Ospedale Sacro Cuore Don Calabria (IT), General Hospital of Athens G. Genimatas (GR), University Hospital of Larissa (GR), Iscare I.V.F (CZ), Instituto de Investigación Marqués de Valdecilla (ES), Azienda Ospedaliero-Universitaria Careggi (IT), Federico II University Hospital (IT), General Hospital of Rhodes (GR), Policlinico Universitario di Catania (IT), Hôpitaux Universitaires Henri-Mondor (FR), Hospital Universitario de La Princesa (ES), The General Hospital of Heraklion "Venizeleio-Pananio" (GR), University Clinical Centre Maribor (SI), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), IRCCS Ospedale San Raffaele (IT), Imelda Hospital (BE), Hospital General Universitario de Alicante Doctor Balmis (ES), University Hospital of Heraklion (GR), Campus Bio Medico University Hospital (IT), Fondazione Poliambulanza Istituto Ospedaliero (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Hospital Universitari Germans Trias i Pujol (ES), White Cross Court Rehabilitation Hospital (GB), Tehniški Solski Center Maribor (SI), IRCCS Humanitas Research Hospital (IT), Azienda Ospedaliera G. Brotzu (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Florence (IT), Universidad Autónoma de Madrid (ES), University of Naples Federico II (IT)
Openalex Percentile: Top 66%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.